Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Ginecol Obstet Mex ; 78(6): 322-8, 2010 Jun.
Artigo em Espanhol | MEDLINE | ID: mdl-20939245

RESUMO

BACKGROUND: Osteoporosis affects 1 in 3 postmenopausal women and is associated with significant morbidity and mortality. The utility of bisphosphonates is often affected by lack of attachment and acceptance of treatment. OBJECTIVE: To analyze the impact of biofeedback in the adherence to once-monthly oral ibandronate treatment. PATIENTS AND METHOD: We designed an open-label, prospective, randomized, multicenter clinical study to investigate the impact of biofeedback with bone turnover markers on adherence to once-monthly oral ibandronate treatment in 781 Mexican and Chilean patients with postmenopausal osteoporosis (BOHEMIA study). They were enrolled at 25 centers in Mexico (700 patients) and 24 centers in Chile (81 patients). All patients received once-monthly oral ibandronate 150 mg for 6 months. Patients without previous bisphosphonate treatment, previous bisphosphonate users, or current bisphosphonate users were included. Patients were randomly divided into two arms at baseline, either to receive biofeedback or not. RESULTS: A statistically significant improvement in adherence was found in patients who received biofeedback when compared with those who did not (98.8 to 99.8% [95% CI] and 95.5 to 97.5%, respectively [p < 0.001]). CONCLUSIONS: Even though biofeedback with bone turnover markers was associated with a significantly greater adherence, it was not great enough to recommend biofeedback as a strategy to achieve optimal adherence. Once-monthly ibandronate by itself can achieve an adequate therapeutic adherence.


Assuntos
Biorretroalimentação Psicológica , Conservadores da Densidade Óssea/administração & dosagem , Difosfonatos/administração & dosagem , Osteoporose Pós-Menopausa/tratamento farmacológico , Cooperação do Paciente , Administração Oral , Idoso , Biomarcadores , Conservadores da Densidade Óssea/efeitos adversos , Conservadores da Densidade Óssea/uso terapêutico , Cálcio/uso terapêutico , Chile , Colágeno Tipo I/sangue , Difosfonatos/efeitos adversos , Difosfonatos/uso terapêutico , Esquema de Medicação , Quimioterapia Combinada , Feminino , Humanos , Ácido Ibandrônico , México , Pessoa de Meia-Idade , Osteoporose Pós-Menopausa/psicologia , Dor/induzido quimicamente , Satisfação do Paciente , Peptídeos/sangue , Estudos Prospectivos , Vitamina D/uso terapêutico
3.
Cir Cir ; 74(4): 257-61, 2006.
Artigo em Espanhol | MEDLINE | ID: mdl-17022897

RESUMO

BACKGROUND: We undertook this study to determine whether anatomic changes after total abdominal hysterectomy are a cause of dyspareunia in premenopausal women. METHODS: This is a comparative, prospective and longitudinal study in 50 premenopausal women with benign uterine disease without dyspareunia treated with total abdominal hysterectomy. Primary variable was presence of postsurgical dyspareunia. Secondary variables are presurgical and assessment 3 months after surgery of left, right, anterior and posterior vaginal longitude (VLL, VRL, VAL and VPL, respectively) expressed in centimeters, as well as of the vaginal volume (VV). Statistical analysis for mean, central tendency and t-test. Group 1 (G1) is comprised of patients with postsurgical dyspareunia and Group 2 (G2) is comprised of patients without dyspareunia. RESULTS: In G1, three patients (mean age: 42 years) had dyspareunia, pre- and postsurgical mean values were VV 146.6 and 100, VLL 8 and 7.3, VPL 9.16 and 7.3, VLL 8 and 7.3, VRL 8 and 7.3. In G2, 47 patients (mean age: 40.36 years) were without dyspareunia, pre- and postsurgical values were VV 150.6 and 121.57, VLL 8.81 and 8.12, VPL 9.7 and 8.69, VLL 9.24 and 8.3, VRL 9.28 and 8.33. We did not find significant differences between the groups. Two of the three patients with dyspareunia had a vaginal granuloma, but the third case did not show an anatomical cause. CONCLUSIONS: There is no relationship between total abdominal hysterectomy in premenopausal women and anatomical vaginal changes after surgery as assessed by vaginal volume and longitude. Presence of vaginal granuloma was responsible for dyspareunia in 4% of cases. Dyspareunia was found in 2% of premenopausal women without posthysterectomy anatomical cause.


Assuntos
Dispareunia/etiologia , Histerectomia/efeitos adversos , Adulto , Feminino , Humanos , Histerectomia/métodos , Pessoa de Meia-Idade , Estudos Prospectivos , Vagina/anatomia & histologia
4.
Cir. & cir ; 74(4): 257-261, jul.-ago. 2006. tab
Artigo em Espanhol | LILACS | ID: lil-575664

RESUMO

Objetivo: conocer si los cambios anatómicos poshisterectomía total abdominal producen dispareunia en pacientes premenopáusicas. Material y métodos: estudio comparativo, prospectivo, longitudinal, de 50 pacientes premenopáusicas sometidas a histerectomía total abdominal por enfermedad uterina benigna sin dispareunia prequirúrgica. Se realizaron valoraciones pre y posperatorias del volumen vaginal y de las longitudes vaginales izquierda, derecha, anterior y posterior. El análisis estadístico se llevó a cabo por medidas de tendencia central y prueba t, agrupando a las pacientes en dos grupos: con dispareunia posoperatoria (grupo I) y sin dispareunia posoperatoria (grupo II). Resultados: grupo I, tres pacientes con los siguientes valores preoperatorios y posoperatorios: volumen vaginal de 146.6 y 100 cm3, longitud vaginal anterior de 8 y 7.3 cm, posterior de 9.16 y 7.3 cm, izquierda de 8 y 7.3 cm, y derecha de 8 y 7.3 cm. Grupo II, 47 pacientes con los siguientes valores preoperatorios y posoperatorios: volumen vaginal de 150.6 y 121.6 cm3, longitud vaginal anterior de 8.81 y 8.12 cm, posterior de 9.7 y 8.69 cm, izquierda de 9.24 y 8.3 cm, y derecha de 9.28 y 8.33 cm. Entre los grupos no encontramos diferencias estadísticamente significativas en volumen ni longitudes vaginales. En dos casos con dispareunia se encontró granuloma en cúpula vaginal que remitió con la resección; en otro no hubo implicación anatómica Conclusiones: no existió relación entre la dispareunia y los cambios de volumen y longitudes vaginales poshisterectomía. El granuloma en la cúpula vaginal fue responsable de 4 % de dispareunia. La dispareunia poshisterectomía total abdominal en paciente premenopáusicas sin causa anatómica aparente se presentó en 2 %.


BACKGROUND: We undertook this study to determine whether anatomic changes after total abdominal hysterectomy are a cause of dyspareunia in premenopausal women. METHODS: This is a comparative, prospective and longitudinal study in 50 premenopausal women with benign uterine disease without dyspareunia treated with total abdominal hysterectomy. Primary variable was presence of postsurgical dyspareunia. Secondary variables are presurgical and assessment 3 months after surgery of left, right, anterior and posterior vaginal longitude (VLL, VRL, VAL and VPL, respectively) expressed in centimeters, as well as of the vaginal volume (VV). Statistical analysis for mean, central tendency and t-test. Group 1 (G1) is comprised of patients with postsurgical dyspareunia and Group 2 (G2) is comprised of patients without dyspareunia. RESULTS: In G1, three patients (mean age: 42 years) had dyspareunia, pre- and postsurgical mean values were VV 146.6 and 100, VLL 8 and 7.3, VPL 9.16 and 7.3, VLL 8 and 7.3, VRL 8 and 7.3. In G2, 47 patients (mean age: 40.36 years) were without dyspareunia, pre- and postsurgical values were VV 150.6 and 121.57, VLL 8.81 and 8.12, VPL 9.7 and 8.69, VLL 9.24 and 8.3, VRL 9.28 and 8.33. We did not find significant differences between the groups. Two of the three patients with dyspareunia had a vaginal granuloma, but the third case did not show an anatomical cause. CONCLUSIONS: There is no relationship between total abdominal hysterectomy in premenopausal women and anatomical vaginal changes after surgery as assessed by vaginal volume and longitude. Presence of vaginal granuloma was responsible for dyspareunia in 4% of cases. Dyspareunia was found in 2% of premenopausal women without posthysterectomy anatomical cause.


Assuntos
Humanos , Feminino , Adulto , Pessoa de Meia-Idade , Dispareunia/etiologia , Histerectomia/efeitos adversos , Histerectomia/métodos , Estudos Prospectivos , Vagina/anatomia & histologia
5.
Gac Med Mex ; 139(3): 276-80, 2003.
Artigo em Espanhol | MEDLINE | ID: mdl-12872421

RESUMO

INTRODUCTION: Hepatic rupture/hemorrhage is a rare but very serious complication associated in most of the cases to pregnancy hypertensive disease. It is an important cause of mother fetal death. OBJECTIVE: Three patients from the Hospital General of Mexico City were evaluated considering clinical evolution and characteristics, therapeutic approach, and a review of the subject in the world literature. MATERIAL AND METHODS: Case 1. a 35 years-old female, with term pregnancy, eutocic delivery, starts presenting symptomatology in immediate postpartum, poor evolution without adequate response, diagnosis of death, sub-capsular hemorrhage. Case 2. a 38-year-old female with term pregnancy, delivers by cesarean operation secondary to AFS finding during surgery, sub-capsular hemorrhage, and right lobe lesion. Leaves hospital. Case 3. a 30-year-old female showing acute abdominal pain in epigastric region, delivery by cesarean operation secondary to PSP, finding during surgery hemorrhage of the Glisson capsule and right hepatic lobe diagnosis is HELLP syndrome, poor evolution, sudden death. COMMENTARY: Hepatic hemorrhage is a rare disorder when it represents an obstetric emergency, due to its elevated association with death for the mother and the fetus; its etiology remain uncertain. Specific symptoms could be established through identification of a triad; epigastric pain; hypotension without evident bleeding cause, and clinical data of hypertensive disease of pregnancy. Prognosis becomes considerably positive if diagnosis is established early; the mortality has diminished with the advent of interventional radiology techniques (selective arterial embolization).


Assuntos
Síndrome HELLP/complicações , Hipertensão/complicações , Hepatopatias/etiologia , Fígado/patologia , Adulto , Evolução Fatal , Feminino , Síndrome HELLP/terapia , Humanos , Hipertensão/terapia , Hepatopatias/terapia , Gravidez , Complicações na Gravidez/etiologia , Complicações na Gravidez/terapia , Ruptura Espontânea
6.
Gac Med Mex ; 139(1): 73-5, 2003.
Artigo em Espanhol | MEDLINE | ID: mdl-12666413

RESUMO

Uterine perforation secondary to placement of intrauterine devices is a rare complication that may affect contiguous organs such as bladder, small intestine, rectum, and sigmoid; all extremely serious depending on the organ involved. We report the case of a 22-year-old woman with complete uterines perforation due to intrauterine device affected that rectum sigmoid with asymptomatic presentation. We emphasize the postoperatory evolution and its management as well as a literature review.


Assuntos
Dispositivos Intrauterinos/efeitos adversos , Perfuração Uterina/diagnóstico , Adulto , Colo Sigmoide/lesões , Colo Sigmoide/cirurgia , Colostomia , Feminino , Humanos , Reto/lesões , Reto/cirurgia , Literatura de Revisão como Assunto , Perfuração Uterina/etiologia , Perfuração Uterina/cirurgia , Útero/lesões , Útero/cirurgia
7.
Rev. méd. Hosp. Gen. Méx ; 62(2): 132-4, abr.-jun. 1999.
Artigo em Espanhol | LILACS | ID: lil-266176

RESUMO

Introducción: En la antigüedad se realizaba extracción del feto de una madre muerta para permitir la inhumación separada; aunque en la actualidad la cesárea postmortem es rara, se efectúa para tratar de salvar el feto. Objetivo: Presentar un caso de operación cesárea postmortem con supervivencia del feto. Presentación del caso: Mujer de 27 años que ingresa al Servicio de Urgencias de Ginecoobstetricia con diagnóstico de embarazo de 39 semanas en trabajo de parto, con preeclampsia severa, presenta crisis convulsiva con broncoaspiración masiva, se le declara muerte. Se realiza operación cesárea postmortem con supervivencia fetal


Assuntos
Feminino , Gravidez , Recém-Nascido , Adulto , Pré-Eclâmpsia/diagnóstico , Pré-Eclâmpsia/mortalidade , Complicações na Gravidez/mortalidade , Sobrevida , Mortalidade Materna , Idade Gestacional , Feto , Cesárea/métodos , Causas de Morte
8.
An. méd. Asoc. Méd. Hosp. ABC ; 41(3 supl): 57-62, jul.-sept. 1996. tab
Artigo em Espanhol | LILACS | ID: lil-200269

RESUMO

El síndrome del ovario poliquístico es una entidad que ha causado gran interés por su frecuencia, por la controversia acerca de su origen y por las repercusiones que conlleva. El estado de anovulación crónico es la vía a través de la cual se originan las alteraciones morfológicas y endocrinas del síndrome, produciendo un complejo sintomático muy variable. Dentro de las alteraciones hormonales más importantes están un hiperandrogenismo y un estado estrogénico aumentado y no antagonizado. Nuestro intés estriba en revisar los factores etiológicos y fisicopatológicos de este síndrome, así como los mecanismos de anovulación implicados


Assuntos
Anovulação/fisiopatologia , Clomifeno/uso terapêutico , Dexametasona/uso terapêutico , Estrona/química , Glândulas Suprarrenais/fisiologia , Glucocorticoides/uso terapêutico , Gonadotropinas/metabolismo , Hiperandrogenismo/etiologia , Obesidade/complicações , Prolactina/metabolismo , Síndrome do Ovário Policístico/etiologia , Síndrome do Ovário Policístico/fisiopatologia
9.
Ginecol. obstet. Méx ; 64(8): 352-5, ago. 1996. tab
Artigo em Espanhol | LILACS | ID: lil-181727

RESUMO

La síntesis de análogos de hormona liberadora de gonadotropinas (GnRH) ha permitido manipular, de manera segura y eficaz, el estado hormonal de las mujeres con endometriosis y crear un estado hipoestrogénico reversible, que ocasiona reducción en los implantes endometriósicos y mejoría de la sintomatología, sin los efectos adversos que se observan con el danazol


Assuntos
Humanos , Feminino , Danazol/efeitos adversos , Endometriose/terapia , Hormônio Liberador de Gonadotropina/administração & dosagem , Hormônio Liberador de Gonadotropina/efeitos adversos , Hormônio Liberador de Gonadotropina/análogos & derivados , Hormônios Liberadores de Hormônios Hipofisários/administração & dosagem , Hormônios Liberadores de Hormônios Hipofisários/efeitos adversos
10.
Ginecol. obstet. Méx ; 64(1): 6-9, ene. 1996.
Artigo em Espanhol | LILACS | ID: lil-181632

RESUMO

Se realizó un estudio retrospectivo, observacional y analítico acerca de la histerectomía obstétrica en pacientes del Hospital General de México durante un periodo de estudio de tres años. El objetivo principal es analizar la histerectomía en el estado grávido puerperal (histerectomía obstétrica), durante la resolución de los problemas que la patología del embarazo, parto y puerperio determinan, así como la asociación de las diversas complicaciones que durante el estado grávido puerperal condicionan la realización de dicho procedimiento, para sí poder disminuir la morbimortalidad. Se analizaron las siguientes variables: edad, antecedentes ginecoobstétricos, indicación quirúrgica, omisión diagnóstica, tipo de cirugía efectuada, cirujanos, tiempo quirúrgico, turno en que se efectuó, reintervención, complicaciones operatorias y transquirúrgicas, utilización de sangre y antibióticos, días de estancia intrahospitalaria y mortalidad. Concluimos que existe la necesidad de identificar una incidencia nacional, conocer las indicaciones más frecuentes, así como la morbimortalidad para poder establecer factores que determinen la disminución de las complicaciones y su mortalidad, además de conocer las pautas a seguir en dicho procedimiento


Assuntos
Humanos , Feminino , Gravidez , Adolescente , Adulto , Histerectomia , Incidência , Estudos Retrospectivos
11.
Ginecol. obstet. Méx ; 63(9): 398-400, sept. 1995.
Artigo em Espanhol | LILACS | ID: lil-161982

RESUMO

Se presenta el caso clínico de una paciente de 16 años de edad, con diagnóstico histopatológico de sarcoma mulleriano mixto heterólogo, entidad poco frecuente en la adolescencia. Asimismo se realiza una revisión de sarcomas del útero, su epidemiología, clasificación, perfil clínico, pronóstico y tratamiento


Assuntos
Adolescente , Humanos , Feminino , Adenossarcoma/diagnóstico , Adenossarcoma/fisiopatologia , Sarcoma , Tumor Mulleriano Misto/diagnóstico , Tumor Mulleriano Misto/fisiopatologia , Neoplasias Uterinas/diagnóstico , Neoplasias Uterinas/fisiopatologia
12.
Ginecol. obstet. Méx ; 63(5): 222-5, mayo 1995. ilus
Artigo em Espanhol | LILACS | ID: lil-151915

RESUMO

La endometriosis en cicatriz quirúrgica es una entidad rara, relacionada comúnmente posterior a un manejo quirúrgico del útero o de la salpinges, o a una laparotomía u otro procedimiento quirúrgico no pélvico, cuando fragmentos del endometrio pueden ser trasplantados fuera de la cavidad uterina. Se presenta el caso de una mujer de 31 años, con el diagnóstico clínico e histopatológico de endometriosis en cicatriz quirúrgica secundaria a una operación cesárea. El tratamiento ofrecido fue la excisión local del tejido anormal, con evolución satisfactoria, sin presentar recurrencias. A la ves se hace una revisión de lo comunicado hasta el momento en la literatura mundial


Assuntos
Adulto , Humanos , Feminino , Cesárea/efeitos adversos , Endometriose/etiologia , Endometriose/fisiopatologia , Endometriose/cirurgia , Cicatrização
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...